Truist Financial’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,729
| Closed | -$216K | – | 2599 |
|
|
2024
Q3 | $216K | Sell |
1,729
-2,274
| -57% | -$284K | ﹤0.01% | 2293 |
|
|
2024
Q2 | $632K | Buy |
4,003
+1,857
| +87% | +$293K | ﹤0.01% | 1835 |
|
|
2024
Q1 | $278K | Sell |
2,146
-430
| -17% | -$55.7K | ﹤0.01% | 2311 |
|
|
2023
Q4 | $248K | Sell |
2,576
-168
| -6% | -$16.2K | ﹤0.01% | 2401 |
|
|
2023
Q3 | $333K | Buy |
+2,744
| New | +$333K | ﹤0.01% | 2159 |
|
|
2022
Q1 | – | Sell |
-2,882
| Closed | -$260K | – | 2799 |
|
|
2021
Q4 | $260K | Sell |
2,882
-1,483
| -34% | -$134K | ﹤0.01% | 2415 |
|
|
2021
Q3 | $404K | Buy |
4,365
+1,425
| +48% | +$132K | ﹤0.01% | 2109 |
|
|
2021
Q2 | $229K | Sell |
2,940
-1,599
| -35% | -$125K | ﹤0.01% | 2495 |
|
|
2021
Q1 | $339K | Sell |
4,539
-5,691
| -56% | -$425K | ﹤0.01% | 2188 |
|
|
2020
Q4 | $1.74M | Sell |
10,230
-2,670
| -21% | -$455K | ﹤0.01% | 1230 |
|
|
2020
Q3 | $1.81M | Buy |
12,900
+4,709
| +57% | +$661K | ﹤0.01% | 1106 |
|
|
2020
Q2 | $1.31M | Buy |
8,191
+121
| +1% | +$19.4K | ﹤0.01% | 1173 |
|
|
2020
Q1 | $790K | Sell |
8,070
-1,609
| -17% | -$158K | ﹤0.01% | 1343 |
|
|
2019
Q4 | $1.25M | Buy |
9,679
+5,163
| +114% | +$666K | ﹤0.01% | 1334 |
|
|
2019
Q3 | $340K | Buy |
4,516
+111
| +3% | +$8.36K | 0.01% | 646 |
|
|
2019
Q2 | $669K | Buy |
4,405
+143
| +3% | +$21.7K | 0.01% | 522 |
|
|
2019
Q1 | $508K | Buy |
4,262
+468
| +12% | +$55.8K | 0.01% | 571 |
|
|
2018
Q4 | $414K | Buy |
3,794
+307
| +9% | +$33.5K | 0.01% | 578 |
|
|
2018
Q3 | $563K | Buy |
3,487
+504
| +17% | +$81.4K | 0.01% | 563 |
|
|
2018
Q2 | $394K | Buy |
+2,983
| New | +$394K | 0.01% | 630 |
|